Verition Fund Management LLC Invests $917,000 in DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS)

Verition Fund Management LLC purchased a new position in shares of DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALSGet Rating) during the 1st quarter, HoldingsChannel reports. The institutional investor purchased 94,020 shares of the company’s stock, valued at approximately $917,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in DALS. Spartan Fund Management Inc. acquired a new stake in shares of DA32 Life Science Tech Acquisition in the 1st quarter valued at approximately $181,000. Sculptor Capital LP grew its stake in shares of DA32 Life Science Tech Acquisition by 165.6% during the 1st quarter. Sculptor Capital LP now owns 763,628 shares of the company’s stock worth $7,419,000 after acquiring an additional 476,127 shares in the last quarter. Ursa Fund Management LLC bought a new position in shares of DA32 Life Science Tech Acquisition during the 1st quarter worth approximately $243,000. Radcliffe Capital Management L.P. bought a new position in shares of DA32 Life Science Tech Acquisition in the first quarter valued at $1,420,000. Finally, Saba Capital Management L.P. bought a new position in shares of DA32 Life Science Tech Acquisition in the first quarter valued at $10,883,000. Institutional investors and hedge funds own 60.43% of the company’s stock.

DA32 Life Science Tech Acquisition Price Performance

NASDAQ:DALS opened at $9.79 on Thursday. The firm has a fifty day simple moving average of $9.73 and a 200 day simple moving average of $9.71. DA32 Life Science Tech Acquisition Corp. has a 1-year low of $9.58 and a 1-year high of $10.26.

DA32 Life Science Tech Acquisition Company Profile

(Get Rating)

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors.

Further Reading

Want to see what other hedge funds are holding DALS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALSGet Rating).

Institutional Ownership by Quarter for DA32 Life Science Tech Acquisition (NASDAQ:DALS)

Receive News & Ratings for DA32 Life Science Tech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DA32 Life Science Tech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.